chr2-61825660-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001201543.2(FAM161A):c.*795G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000067 in 417,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000075 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000063 ( 0 hom. )
Consequence
FAM161A
NM_001201543.2 3_prime_UTR
NM_001201543.2 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.120
Genes affected
FAM161A (HGNC:25808): (FAM161 centrosomal protein A) This gene belongs to the FAM161 family. It is expressed mainly in the retina. Mouse studies suggested that this gene is involved in development of retinal progenitors during embryogenesis, and that its activity is restricted to mature photoreceptors after birth. Mutations in this gene cause autosomal recessive retinitis pigmentosa-28. Alternatively spliced transcript variants have been identified.[provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAM161A | NM_001201543.2 | c.*795G>A | 3_prime_UTR_variant | 7/7 | ENST00000404929.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAM161A | ENST00000404929.6 | c.*795G>A | 3_prime_UTR_variant | 7/7 | 1 | NM_001201543.2 | P1 | ||
FAM161A | ENST00000405894.3 | c.*795G>A | 3_prime_UTR_variant | 6/6 | 1 | ||||
FAM161A | ENST00000456262.5 | c.*2293G>A | 3_prime_UTR_variant, NMD_transcript_variant | 6/6 | 1 | ||||
FAM161A | ENST00000418113.5 | c.*1418G>A | 3_prime_UTR_variant, NMD_transcript_variant | 8/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000750 AC: 11AN: 146632Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
11
AN:
146632
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000490 AC: 5AN: 101992Hom.: 0 AF XY: 0.0000178 AC XY: 1AN XY: 56170
GnomAD3 exomes
AF:
AC:
5
AN:
101992
Hom.:
AF XY:
AC XY:
1
AN XY:
56170
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000627 AC: 17AN: 271256Hom.: 0 Cov.: 0 AF XY: 0.0000578 AC XY: 9AN XY: 155816
GnomAD4 exome
AF:
AC:
17
AN:
271256
Hom.:
Cov.:
0
AF XY:
AC XY:
9
AN XY:
155816
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000750 AC: 11AN: 146632Hom.: 0 Cov.: 31 AF XY: 0.0000986 AC XY: 7AN XY: 70996
GnomAD4 genome
AF:
AC:
11
AN:
146632
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
70996
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Retinitis pigmentosa Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at